Major cancer breakthrough
Published: July 3, 2006
A CAMBRIDGE company has made an important breakthrough in cancer treatment.
Two years ago Delta G, formed by William Bains, received £130,000 of funding to work on the ideas of Dr Aubrey de Grey, a Cambridge researcher. Dr de Grey’s work concentrates on the metabolism of cells and what goes wrong as they age.
Cancer cells use the energy they get from metabolism abnormally - a difference that many scientists have tried to fathom. Now, Delta G has discovered exactly what is wrong with cancer cells, allowing researchers to target them more effectively.
Delta G has filed its first patent, and hopes this is the start of a new approach to cancer treatment.
Prof Bains said: “This approach is likely to be particularly suitable for late-stage lung, colon and breast cancers, which kill more than 800,000 people a year in the West. A drug that offers a new approach to treatment would be of tremendous value.”
NESTA (National Endowment for Science, Technology and the Arts) chief executive, Jonathan Kestenbaum, said:
“Delta G is set to make a major impact in the field of cell research.”
The company has also been working on a new treatment for Chronic Fatigue Syndrome, which is suffered by one in 400 people. Currently, the only effective treatment is a combination of graded exercise and therapy which can take years.
Delta G aims to refine its ideas in the lab and then sell them on to the major drugs companies to develop into medicines.
If you enjoyed this good news Subscribe to Good News Blog
Share this
To share this simply copy and paste one of the below URL's: